Treatment satisfaction and quality of life in patients treated with fingolimod

BACKGROUND: The development of oral treatments for relapsing–remitting multiple sclerosis (RRMS) may alter patient satisfaction and quality of life (QoL). The aim of this survey was to evaluate treatment satisfaction and QoL in patients treated with fingolimod in everyday clinical practice in France...

Descripción completa

Detalles Bibliográficos
Autores principales: Mékiès, Claude, Heinzlef, Olivier, Jenny, Béatrice, Ramelli, Anne-Laure, Clavelou, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973401/
https://www.ncbi.nlm.nih.gov/pubmed/29872275
http://dx.doi.org/10.2147/PPA.S144021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973401/
https://www.ncbi.nlm.nih.gov/pubmed/29872275
http://dx.doi.org/10.2147/PPA.S144021

Ejemplares similares